Pavel Yufit, MD of Mehling Orthopedics Named NJ Top Doc For 2023
NJ Top Docs has reviewed and approved Pavel Yufit, MD of Mehling Orthopedics for 2023. Dr. Pavel Yufit is a board-certified orthopedic surgeon specializing in trauma treatment. He has been practicing medicine for over 15 years. Always a stellar student, Dr. Yufit graduated summa cum laude from Boston University in Boston, Massachusetts with a Bachelor of Arts in biochemistry and molecular biology in 2000. Dr. Yufit later earned his medical doctorate from the prestigious New York University School of Medicine in New York City in...
read moreBrian Mehling, MD of Mehling Orthopedics Named NJ Top Doc For 2023
NJ Top Docs has reviewed and approved Brian Mehling, MD of Mehling Orthopedics for 2023. Dr. Brian Mehling is a board-certified orthopedic trauma surgeon specializing in regenerative medicine. He is also board certified by the American Academy of Anti-Aging Medicine. Outside of his clinic work, Dr. Mehling is a respected researcher and philanthropist. Dr. Mehling’s path to medicine started during his undergraduate studies at The Ohio State University in Columbus, Ohio, where he obtained his Bachelor of Arts and Master of Science...
read moreNJ Top Docs 2022, Dr, Brian Mehling and Dr. Pavel Yufit Specialize in Trauma Treatment
NJ Top Docs has reviewed and approved board-certified orthopedic surgeons, Brian Mehling, MD and Pavel Yufit, MD of Mehling Orthopedics for 2022. Both are fellows of the American Academy of Orthopedic Surgeons and specialize in trauma treatment. They are also members of the Orthopaedic Trauma Association. Their practice, Mehling Orthopedics is an orthopedic trauma practice dedicated to creating individualized treatment plans for traumatic injuries and disabilities. Dr. Mehling started his path in medicine through undergraduate study at...
read moreWORLD-RENOWNED STEM CELL RESEARCHER, BRIAN MEHLING, MD, SET TO ATTEND THE ANNUAL WORLD ECONOMIC FORUM IN DAVOS
ZURICH, Switzerland – May 4, 2022 – Brian Mehling, MD, a world-renowned stem cell researcher, board-certified orthopedic trauma surgeon, board-certified in anti-aging medicine, and founder of Blue Horizon International (BHI), will be attending the Annual World Economic Forum (WEF) in Davos from May 22-26. This will be Dr. Mehling’s ninth year attending the global conference. The 52nd Annual Meeting will convene on the theme “Working Together, Restoring Trust,” with the aim to address economic, environmental, political and social...
read moreBlue Horizon International and Mehling Orthopedics to exhibit at American Academy Of Orthopaedic Surgeons Annual Meeting in Chicago
Brian Mehling, M.D. and Pavel Yufit, M.D., orthopedic surgeons with practices in New York and New Jersey, are scheduled to attend the 2022 Annual Meeting of the American Academy of Orthopaedic Surgeons in Chicago, Illinois from March 22-26, 2022 at the McCormick Place Convention Center. The booth number is 1904. This is the world’s largest meeting of orthopaedic surgeons, researchers, and allied health professionals. The meeting offers physicians the opportunity to exchange ideas with their colleagues and learn about cutting-edge...
read moreBrian Mehling, MD slated to participate in the 19th Annual World Congress of Society for Brain Mapping and Therapeutics
Breaking Boundaries of Science, Technology, Medicine, Art, and Healthcare Policy meeting being held in LA March 10-13 Brian Mehling, MD, founder and chief medical officer of BHI Therapeutic Sciences, will virtually present on three topics at the 19th Annual World Congress of Society for Brain Mapping and Therapeutics. The meeting, entitled Breaking Boundaries of Science, Technology, Medicine, Art, and Healthcare Policy, will be held at the Los Angeles Convention Center, March 10-13. Dr. Mehling will speak on the following: Safety study...
read moreBHI CEO Participates in Patient Safety Workshop Sponsored by the Joint Commission
Doreen Santora, RN, MHA Doreen Santora, RN, MHA, chief executive officer of Blue Horizon International (BHI) and its subsidiaries, including BHI Therapeutic Sciences, recently participated the Joint Commission International (JCI) program titled Managing Patient Safety Events: A Root Cause Analysis Workshop. The two-day, live virtual workshop provided participants with the knowledge, skills, and strategies to establish a standardized approach to managing patient safety events, including sentinel events. “BHI Therapeutic Sciences is...
read moreBRIAN MEHLING, MD EARNS ANTI-AGING AND REGENERATIVE MEDICINE BOARD CERTIFICATION
Brian Mehling, MD has successfully completed all components of the Board Certification in the field of Anti-Aging and Regenerative Medicine.Dr. Mehling is the founder and chief medical officer of Mehling Orthopedics and BHI Therapeutic Sciences (BHITS). He is a practicing American orthopedic trauma surgeon, researcher, and philanthropist. He spearheads groundbreaking research in stem cell therapy. Notably, BHITS is currently engaged in an FDA Investigational New Drug trial for stroke, using human umbilical cord blood (hUCB) stem...
read moreBrian Mehling, M.D., and team travel to Monaco for potential investors
Brian Mehling, M.D., M.S.founder and chief medical officer of Blue Horizon International (BHI) and his team traveled to Monaco and Paris, France in November 2021, attending a series of meetings with potential investors and partners to expand access to stem cell therapeutics. #BlueHorizonStemCells #StemCellTherapy #Monaco...
read moreBrian Mehling, M.D. and his team attended the Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) at the San Diego Convention Center
Brian Mehling, M.D. and his team attended the Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) at the San Diego Convention Center, CA from August 31- September 3, 2021.AAOS is the world’s largest meeting of orthopaedic surgeons, researchers, and allied health professionals.Dr. Mehling is the chief medical officer at BHI Therapeutic Sciences, LLC, a company that offers a novel method of arthritis therapy using a patient’s own stromal vascular fraction (SVF) cells including mesenchymal stem cells.BHI Therapeutic...
read more
